Position in BIIB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$61,132,671
+$9,328,783 QoQ
Shares Held
333,457
+13.3% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,579,687,180 across 10 Drug Manufacturers - General names. BIIB ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
956,817 | $880,051,572 | |
| 2 | JNJ |
Johnson & Johnson
|
2,463,008 | $602,057,675 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,687,439 | $323,272,037 | |
| 4 | ABBV |
AbbVie Inc.
|
1,470,271 | $319,769,239 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
916,513 | $127,734,416 | |
| 6 | AMGN |
Amgen Inc
|
342,500 | $120,508,625 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,466,671 | $88,953,596 | |
| 8 | BIIB |
Biogen Inc.
This page
|
333,457 | $61,132,671 |
All Filings in BIIB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,132,671 | 333,457 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $51,803,888 | 294,357 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $46,525,050 | 332,132 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,138,407 | 247,937 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,683,756 | 70,767 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $8,877,678 | 45,799 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,921,382 | 137,699 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $54,248,626 | 251,582 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $92,072,436 | 355,808 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,650,623 | 60,895 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $114,525,651 | 402,056 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $92,312,354 | 332,023 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $61,642,115 | 222,599 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $66,162,333 | 247,799 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $31,100,646 | 152,499 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,874,829 | 18,399 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $43,545,240 | 181,499 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $32,005,886 | 113,099 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $46,884,611 | 135,399 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $48,113,363 | 171,987 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $41,549,558 | 169,687 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $50,177,318 | 176,880 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $14,873,104 | 55,590 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $65,139,478 | 205,890 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||